Top Menu

Author Archive | Carly Helfand

Lung cancer screening awareness is low. How can the industry get the word out?

Certain cancer screening types, including mammograms and colonoscopies, are well-known among patients. But lung cancer screening isn’t one of them—and even high-risk patients aren’t getting the message. More than half of current smokers—54%—know little or nothing about lung-cancer screening, according to recent data from Phreesia Life Sciences, which surveyed more than 14,000 current and former smokers […]

Continue Reading 0

How Can Pharma Help More Chronically Ill Patients? Engage Their Caregivers Directly, Survey Says

Pharma companies don’t typically market directly to caregivers of patients with chronic conditions. But they might want to consider it, new data from Phreesia Life Sciences suggests. More than half of chronically ill patients rely on their caregivers to make healthcare decisions for them, according to a nationwide survey of more than 2,000 caregivers conducted […]

Continue Reading 0
Source: Mohamed_Hassan via Pixabay

New CGRP Drugs are Flooding the Migraine Market—But They’re Not Making a Splash with Patients

Since May 2018, several calcitonin gene-related peptide (CGRP) inhibitors have entered the migraine field, with no fewer than seven gaining U.S. Food & Drug Administration approval for acute migraine treatment and/or prevention. Thanks to this influx of new prescription therapies, the global migraine market is expanding, with some analysts expecting to see its value soar […]

Continue Reading 0